Dova Pharmaceuticals, Inc
Dova Pharmaceuticals, Inc (DOVA) related to its sale to Swedish Orphan Biovirtum AB. Dova shareholders have the right to receive $27.50 in cash per Dova common stock owned and one Contingent Value Right of $1.50 per share of Dova common stock owned.